Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Balance Sheet

MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
Best 1M Momentum Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Balance Sheet History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
EQUITY AND LIABILITIES
Share Capital ₹41 Cr₹40 Cr₹40 Cr₹40 Cr₹40 Cr
    Equity - Authorised ₹228 Cr₹209 Cr₹41 Cr₹41 Cr₹41 Cr
    Equity - Issued ₹41 Cr₹40 Cr₹40 Cr₹40 Cr₹40 Cr
    Equity Paid Up ₹41 Cr₹40 Cr₹40 Cr₹40 Cr₹40 Cr
    Equity Shares Forfeited -----
    Adjustments to Equity -----
    Preference Capital Paid Up -----
    Face Value ₹1.00₹1.00₹1.00₹1.00₹1.00
Share Warrants & Outstandings ₹44 Cr₹23 Cr₹0.06 Cr--
Total Reserves ₹14,247 Cr₹9,300 Cr₹7,395 Cr₹6,115 Cr₹4,682 Cr
    Securities Premium ₹3,008 Cr₹42 Cr₹42 Cr₹42 Cr₹42 Cr
    Capital Reserves ₹-909 Cr₹-909 Cr₹-909 Cr₹-909 Cr₹-909 Cr
    Profit & Loss Account Balance ₹11,907 Cr₹9,919 Cr₹8,012 Cr₹6,735 Cr₹5,304 Cr
    General Reserves ₹238 Cr₹238 Cr₹238 Cr₹238 Cr₹238 Cr
    Other Reserves ₹3.84 Cr₹10 Cr₹12 Cr₹9.11 Cr₹7.56 Cr
Reserve excluding Revaluation Reserve ₹14,247 Cr₹9,300 Cr₹7,395 Cr₹6,115 Cr₹4,682 Cr
Revaluation reserve -----
Shareholder's Funds ₹14,332 Cr₹9,363 Cr₹7,435 Cr₹6,155 Cr₹4,722 Cr
Minority Interest ₹236 Cr₹213 Cr₹188 Cr₹161 Cr₹141 Cr
Long-Term Borrowings -----
Secured Loans ₹5,078 Cr₹25 Cr₹23 Cr₹49 Cr₹57 Cr
    Non Convertible Debentures ₹4,943 Cr----
    Converible Debentures & Bonds -----
    Packing Credit - Bank -----
    Inter Corporate & Security Deposit -----
    Term Loans - Banks ₹396 Cr₹43 Cr₹45 Cr₹67 Cr₹69 Cr
    Term Loans - Institutions -----
    Other Secured ₹-261 Cr₹-19 Cr₹-22 Cr₹-18 Cr₹-11 Cr
Unsecured Loans ₹448 Cr--₹0.25 Cr₹0.25 Cr
    Fixed Deposits - Public -----
    Loans and advances from subsidiaries -----
    Inter Corporate Deposits (Unsecured) -----
    Foreign Currency Convertible Notes -----
    Long Term Loan in Foreign Currency -----
    Loans - Banks ₹131 Cr----
    Loans - Govt. -----
    Loans - Others ₹317 Cr--₹0.25 Cr₹0.25 Cr
    Other Unsecured Loan -----
Deferred Tax Assets / Liabilities ₹1,705 Cr₹8.68 Cr₹48 Cr₹16 Cr₹-36 Cr
    Deferred Tax Assets ₹728 Cr₹454 Cr₹315 Cr₹228 Cr₹193 Cr
    Deferred Tax Liability ₹2,432 Cr₹463 Cr₹362 Cr₹244 Cr₹157 Cr
Other Long Term Liabilities ₹34 Cr₹31 Cr₹31 Cr₹23 Cr₹13 Cr
Long Term Trade Payables -----
Long Term Provisions ₹155 Cr₹123 Cr₹98 Cr₹80 Cr₹72 Cr
Total Non-Current Liabilities ₹7,420 Cr₹187 Cr₹199 Cr₹169 Cr₹107 Cr
Current Liabilities -----
Trade Payables ₹1,133 Cr₹777 Cr₹1,008 Cr₹1,076 Cr₹667 Cr
    Sundry Creditors ₹1,133 Cr₹777 Cr₹1,008 Cr₹1,076 Cr₹667 Cr
    Acceptances -----
    Due to Subsidiaries- Trade Payables -----
Other Current Liabilities ₹1,335 Cr₹756 Cr₹386 Cr₹473 Cr₹283 Cr
    Bank Overdraft / Short term credit ---₹11 Cr₹39 Cr
    Advances received from customers ₹33 Cr₹27 Cr₹26 Cr₹17 Cr₹12 Cr
    Interest Accrued But Not Due ₹183 Cr----
    Share Application Money -----
    Current maturity of Debentures & Bonds -----
    Current maturity - Others -----
    Other Liabilities ₹1,120 Cr₹728 Cr₹360 Cr₹446 Cr₹231 Cr
Short Term Borrowings ₹2,513 Cr₹151 Cr₹115 Cr₹795 Cr₹158 Cr
    Secured ST Loans repayable on Demands ₹505 Cr₹151 Cr₹115 Cr₹731 Cr₹148 Cr
    Working Capital Loans- Sec ₹497 Cr₹151 Cr₹115 Cr₹731 Cr₹148 Cr
    Buyers Credits - Unsec -----
    Commercial Borrowings- Unsec -----
    Other Unsecured Loans ₹1,512 Cr₹-151 Cr₹-115 Cr₹-668 Cr₹-139 Cr
Short Term Provisions ₹682 Cr₹436 Cr₹354 Cr₹280 Cr₹245 Cr
    Proposed Equity Dividend -----
    Provision for Corporate Dividend Tax -----
    Provision for Tax ₹18 Cr₹8.38 Cr₹46 Cr₹15 Cr₹11 Cr
    Provision for post retirement benefits -----
    Preference Dividend -----
    Other Provisions ₹664 Cr₹427 Cr₹308 Cr₹265 Cr₹234 Cr
Total Current Liabilities ₹5,664 Cr₹2,120 Cr₹1,863 Cr₹2,623 Cr₹1,353 Cr
Total Liabilities ₹27,652 Cr₹11,883 Cr₹9,686 Cr₹9,108 Cr₹6,324 Cr
ASSETS
Gross Block ₹20,917 Cr₹5,910 Cr₹5,233 Cr₹4,247 Cr₹2,160 Cr
Less: Accumulated Depreciation ₹1,912 Cr₹1,370 Cr₹988 Cr₹664 Cr₹501 Cr
Less: Impairment of Assets -----
Net Block ₹19,004 Cr₹4,540 Cr₹4,245 Cr₹3,583 Cr₹1,659 Cr
Lease Adjustment A/c -----
Capital Work in Progress ₹306 Cr₹207 Cr₹493 Cr₹670 Cr₹372 Cr
Non Current Investments ₹351 Cr₹310 Cr₹271 Cr₹235 Cr₹206 Cr
Long Term Investment ₹351 Cr₹310 Cr₹271 Cr₹235 Cr₹206 Cr
    Quoted -----
    Unquoted ₹411 Cr₹364 Cr₹325 Cr₹285 Cr₹263 Cr
Long Term Loans & Advances ₹293 Cr₹164 Cr₹188 Cr₹164 Cr₹158 Cr
Other Non Current Assets ₹189 Cr₹14 Cr₹99 Cr₹13 Cr₹17 Cr
Total Non-Current Assets ₹20,663 Cr₹5,315 Cr₹5,358 Cr₹4,702 Cr₹2,417 Cr
Current Assets Loans & Advances -----
Currents Investments ₹1,691 Cr₹2,258 Cr₹1,075 Cr₹874 Cr₹1,306 Cr
    Quoted ₹1,691 Cr₹2,258 Cr₹1,075 Cr₹874 Cr₹1,306 Cr
    Unquoted -----
Inventories ₹2,094 Cr₹1,553 Cr₹1,498 Cr₹1,760 Cr₹1,184 Cr
    Raw Materials ₹552 Cr₹409 Cr₹414 Cr₹399 Cr₹284 Cr
    Work-in Progress ₹186 Cr₹100 Cr₹86 Cr₹94 Cr₹73 Cr
    Finished Goods ₹300 Cr₹263 Cr₹285 Cr₹310 Cr₹224 Cr
    Packing Materials -----
    Stores  and Spare ₹46 Cr₹44 Cr₹35 Cr₹24 Cr₹12 Cr
    Other Inventory ₹1,010 Cr₹738 Cr₹678 Cr₹934 Cr₹591 Cr
Sundry Debtors ₹1,538 Cr₹848 Cr₹576 Cr₹388 Cr₹331 Cr
    Debtors more than Six months ₹68 Cr₹44 Cr₹21 Cr₹15 Cr₹10 Cr
    Debtors Others ₹1,531 Cr₹832 Cr₹575 Cr₹385 Cr₹325 Cr
Cash and Bank ₹555 Cr₹708 Cr₹453 Cr₹406 Cr₹701 Cr
    Cash in hand ₹0.55 Cr₹0.74 Cr₹0.46 Cr₹0.25 Cr₹0.19 Cr
    Balances at Bank ₹554 Cr₹707 Cr₹453 Cr₹403 Cr₹701 Cr
    Other cash and bank balances ---₹2.29 Cr-
Other Current Assets ₹97 Cr₹104 Cr₹64 Cr₹171 Cr₹83 Cr
    Interest accrued on Investments -----
    Interest accrued on Debentures -----
    Deposits with Government -----
    Interest accrued and or due on loans -----
    Prepaid Expenses ₹61 Cr₹60 Cr₹33 Cr₹136 Cr₹37 Cr
    Other current_assets ₹36 Cr₹44 Cr₹31 Cr₹35 Cr₹46 Cr
Short Term Loans and Advances ₹1,011 Cr₹1,093 Cr₹657 Cr₹804 Cr₹276 Cr
    Advances recoverable in cash or in kind ₹91 Cr₹42 Cr₹77 Cr₹73 Cr₹39 Cr
    Advance income tax and TDS -----
    Amounts due from directors -----
    Due From Subsidiaries -----
    Inter corporate deposits -----
    Corporate Deposits -----
    Other Loans & Advances ₹919 Cr₹1,052 Cr₹580 Cr₹731 Cr₹237 Cr
Total Current Assets ₹6,986 Cr₹6,566 Cr₹4,325 Cr₹4,404 Cr₹3,880 Cr
Net Current Assets (Including Current Investments) ₹1,322 Cr₹4,446 Cr₹2,461 Cr₹1,780 Cr₹2,526 Cr
Miscellaneous Expenses not written off -----
Total Assets ₹27,652 Cr₹11,883 Cr₹9,686 Cr₹9,108 Cr₹6,324 Cr
Contingent Liabilities ₹1,019 Cr₹89 Cr₹48 Cr₹83 Cr₹35 Cr
Total Debt ₹8,300 Cr₹196 Cr₹163 Cr₹868 Cr₹235 Cr
Book Value -233.15185.61153.65117.88
Adjusted Book Value 346.31233.15185.61153.65117.88

Compare Balance Sheet of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹108,902.8 Cr 2.3% 5.9% 4.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹395,626.0 Cr 2% 1.4% -13% Stock Analytics
DIVIS LABORATORIES ₹161,996.0 Cr 1.3% 0.3% 10.4% Stock Analytics
CIPLA ₹127,494.0 Cr 0.3% 1.9% -6.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹120,718.0 Cr 0% -2.3% 2.6% Stock Analytics
DR REDDYS LABORATORIES ₹110,374.0 Cr 0.5% 6.2% -1.4% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

2.3%

5.9%

4.6%

SENSEX

1.8%

2.1%

0.2%


You may also like the below Video Courses